Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution

Abstract
Background—Immunoadsorption (IA) and subsequent immunoglobulin (Ig) G substitution represent an additional therapeutic approach in dilated cardiomyopathy (DCM). It remains to be elucidated whether this treatment modulates myocardial inflammation, which is possibly a causal factor of ventricular dysfunction.Methods and Results—From 25 DCM patients (EF PP2(PPP2(PPPConclusions—IA and subsequent IgG substitution mitigate myocardial inflammation in DCM.

This publication has 16 references indexed in Scilit: